Skip to main content

A PHASE Ib STUDY EVALUATING COBIMETINIB PLUS ATEZOLIZUMAB IN PATIENTS WITH ADVANCED BRAFV600 WILD-TYPE MELANOMA WHO HAVE PROGRESSED DURING OR AFTER TREATMENT WITH ANTI¿PD-1 THERAPY

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

F. Hoffmann-La Roche Ltd

Start Date

March 17, 2017

End Date

February 28, 2020
 

Administered By

Ophthalmology

Awarded By

F. Hoffmann-La Roche Ltd

Start Date

March 17, 2017

End Date

February 28, 2020